Generic placeholder image

Current Radiopharmaceuticals

Editor-in-Chief

ISSN (Print): 1874-4710
ISSN (Online): 1874-4729

Editorial

New Advances in Mammography as Guidance for Vacuum-assisted Breast Biopsy: A Complete Tool for Radiologists

Author(s): Daniele Ugo Tari*

Volume 17, Issue 2, 2024

Published on: 20 October, 2023

Page: [117 - 119] Pages: 3

DOI: 10.2174/0118744710242014231016094608

Price: $65

Next »
[1]
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(3): 209-49.
[http://dx.doi.org/10.3322/caac.21660]
[2]
Senapati GM, Chikarmane SA, Denison CM, Giess CS. Feasibility and accuracy of digital breast tomosynthesis–guided vacuum-assisted breast biopsy for noncalcified mammographic targets. Diagn Interv Radiol 2022; 28(2): 171-8.
[http://dx.doi.org/10.5152/dir.2022.20830] [PMID: 35548902]
[3]
Skaane P, Bandos AI, Gullien R, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a populationbased screening program. Radiology 2013; 267(1): 47-56.
[http://dx.doi.org/10.1148/radiol.12121373] [PMID: 23297332]
[4]
Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 2014; 311(24): 2499-507.
[http://dx.doi.org/10.1001/jama.2014.6095] [PMID: 25058084]
[5]
Huang ML, Adrada BE, Candelaria R, Thames D, Dawson D, Yang WT. Stereotactic breast biopsy: Pitfalls and pearls. Tech Vasc Interv Radiol 2014; 17(1): 32-9.
[http://dx.doi.org/10.1053/j.tvir.2013.12.006] [PMID: 24636329]
[6]
Jackman RJ, Marzoni FA Jr. Stereotactic histologic biopsy with patients prone: Technical feasibility in 98% of mammographically detected lesions. AJR Am J Roentgenol 2003; 180(3): 785-94.
[http://dx.doi.org/10.2214/ajr.180.3.1800785] [PMID: 12591697]
[7]
Rochat CJ, Baird GL, Lourenco AP. Digital Mammography stereotactic biopsy versus digital breast tomosynthesis–guided biopsy: Differ-ences in biopsy targets, pathologic results, and discordance rates. Radiology 2020; 294(3): 518-27.
[http://dx.doi.org/10.1148/radiol.2019191525] [PMID: 31961261]
[8]
Bahl M, Maunglay M, D’Alessandro HA, Lehman CD. Comparison of upright digital breast tomosynthesis–guided versus prone stereotactic vacuum-assisted breast biopsy. Radiology 2019; 290(2): 298-304.
[http://dx.doi.org/10.1148/radiol.2018181788] [PMID: 30511909]
[9]
Scaperrotta GP, Boffelli G, Depretto C, et al. Guiding vacuum-assisted biopsy in prone position: Digital breast tomosynthesis vs. stereotac-tic. Tumori 2022; 108(4): 326-30.
[http://dx.doi.org/10.1177/03008916211016101] [PMID: 34041978]
[10]
Schrading S, Distelmaier M, Dirrichs T, et al. Digital breast tomosynthesis-guided vacuum-assisted breast biopsy: Initial experiences and comparison with prone stereotactic vacuum-assisted biopsy. Radiology 2015; 274(3): 654-62.
[http://dx.doi.org/10.1148/radiol.14141397] [PMID: 25386875]
[11]
Vijapura CA, Wahab RA, Thakore AG, Mahoney MC. Upright Tomosynthesis-guided Breast Biopsy: Tips, Tricks, and Troubleshooting. Radiographics 2021; 41(5): 1265-82.
[http://dx.doi.org/10.1148/rg.2021210017] [PMID: 34357806]
[12]
Patel IJ, Rahim S, Davidson JC, et al. Society of interventional radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions—part ii: Recommendations. J Vasc Interv Radiol 2019; 30(8): 1168-1184.e1.
[http://dx.doi.org/10.1016/j.jvir.2019.04.017] [PMID: 31229333]
[13]
Tari DU, Pinto F. Mammography in breast disease screening and diagnosis. J Pers Med 2023; 13(2): 228.
[http://dx.doi.org/10.3390/jpm13020228] [PMID: 36836462]
[14]
Alcantara R, Posso M, Pitarch M, et al. Contrast-enhanced mammography-guided biopsy: Technical feasibility and first outcomes. Eur Radiol 2022; 33(1): 417-28.
[http://dx.doi.org/10.1007/s00330-022-09021-w] [PMID: 35895121]
[15]
Tari DU, Morelli L, Guida A, Pinto F. Male breast cancer review. A rare case of pure DCIS: Imaging protocol, radiomics and management. Diagnostics (Basel) 2021; 11(12): 2199.
[http://dx.doi.org/10.3390/diagnostics11122199] [PMID: 34943439]
[16]
Lucioni M, Rossi C, Lomoro P, et al. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): Is surgical excision still recommended? Eur Radiol 2021; 31(2): 920-7.
[http://dx.doi.org/10.1007/s00330-020-07161-5] [PMID: 32816199]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy